Nepsilon-(2,4-Dinitrophenyl)-L-lysine Hydrochloride>98.0%(HPLC)1g

Methyl 2-Fluoronicotinate, 97.0%, 10g

(7-Methoxy-2-methyl-1H-indol-3-yl)-acetic acid, 95.0%, 250mg

5-Bromo-1-methyl-2-oxo-1,2-dihydropyridine-3-carboxylic acid, 95.0%, 1g

3-Chloroimidazo[1,2-a]pyrazine, 98%, 1g

3-(4,5-Dihydro-4,4-dimethyloxazol-2-yl)aniline, 95.0%, 250mg

Quinoxaline-2(1h)-thione, 98%, 50g

2-(4-methylphenyl)-2-propanamine hydrochloride, 95.0%, 1g

(5,6,7,8-TETRAHYDROIMIDAZO[1,2-A]PYRIDIN-6-YL)METHANOL, 95.0%, 100mg

6-hydroxy-2-(4-nitrophenyl)-1,4-dihydropyrimidin-4-one, 10g

FAK ligand-Linker Conjugate 1, 10mg

Methyl 4-methoxybicyclo[2.2.2]octane-1-carboxylate, 98%, 500mg

(2S,5R)-Benzyl 5-((benzyloxy)amino)piperidine-2-carboxylate oxalate, 98%, 5g